Updated:
618 Longevity Partners
618 Longevity Partners is a single-family office investing in longevity, biotechnology, and healthcare services.
618 Longevity Partners
618 Longevity Partners is a single-family office established to invest in the longevity and healthcare sectors. The firm's founding principal has not been publicly identified, and the wealth origin remains undisclosed. The office is structured to manage capital with a thematic focus on aging and life extension. The firm targets investments across biotechnology, healthcare services, and wellness. Its portfolio includes direct stakes in companies developing therapies for age-related diseases and diagnostic tools. Geographic focus appears to be North America, with potential exposure to European and Asian markets through partnerships. Deal structures include direct co-investments and venture capital-style allocations. Team size and additional office locations are not publicly available. No recent operational events have been reported. The firm operates without transparent disclosure of its total deployment or AUM. A distinguishing feature is its thematic concentration on longevity—a niche within healthcare investing. This narrow mandate differentiates it from broadly diversified family offices. Succession and governance details are unknown.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Sector focus
Frequently asked questions
Who runs investment decisions at 618 Longevity Partners?
The investment decision-making team at 618 Longevity Partners has not been publicly disclosed. The firm does not list executives or investment professionals on its website or in public records.
What investment stages does 618 Longevity Partners typically target?
Based on available information, the firm appears to target a range of stages, including early-stage biotechnology ventures and later-stage healthcare companies. The firm may participate in venture capital rounds and direct investments.
Which sectors does 618 Longevity Partners explicitly avoid?
The firm's focus on longevity and healthcare implies it avoids sectors unrelated to human health and aging, such as traditional energy, real estate, or consumer goods. No explicit exclusions are documented.
Is 618 Longevity Partners structured as a single family office or does it operate more like a venture firm?
The firm is structured as a single-family office. Its investment approach includes direct co-investments and venture capital-style allocations, but it operates as a private capital vehicle for a single family rather than as a fund management firm.
How does 618 Longevity Partners source proprietary deal flow?
Deal flow is likely sourced through the founding principal's network, industry conferences, and relationships with academic research institutions and biotechnology companies. The firm does not publicly detail its sourcing methodology.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: